ProCell(R) Receives CE Marked Approval for Selling Into the European Union

2 years ago

BOSTON, MA / ACCESSWIRE / February 9, 2024 / ProCell® Surgical Inc. has successfully been registered and is certified to…

Autonomix Medical, Inc. (NASDAQ:AMIX) to Present at Integrous Big Hearts, Big Ideas Virtual Investor Conference

2 years ago

Webcast presentation on Wednesday, February 14th at 10:30 AM ESTTHE WOODLANDS, TX / ACCESSWIRE / February 9, 2024 / Autonomix…

Caira Surgical to Present Innovative Radar Surgical Tracking at CG 2024 Musculoskeletal Conference

2 years ago

CEO Jon Greenwald to Present at 4:30 p.m. in the Georgian Room Jon Greenwald, Chief Executive Officer at Caira Surgical…

Correction: Nuvectis Pharma Announces Participation at Upcoming Investor Conferences

2 years ago

Fort Lee, NJ, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage…

Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational Highlights

2 years ago

- Year-over-year revenue increased 114% for the fiscal second quarter and 337% for the six-months ending December 31, 2023 -…

PharmAla and Red Light Holland to Collaborate on Medical Psilocybin Development

2 years ago

PharmAla will consult on GMP Drug Product and Regulatory Development for Red Light HollandVANCOUVER, British Columbia, Feb. 09, 2024 (GLOBE…

MaxCyte to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 and Participate in Upcoming Investor Conferences

2 years ago

ROCKVILLE, Md., Feb. 09, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing…

OneMedNet Sees Real World Data Growth in Women’s Health

2 years ago

MINNEAPOLIS, Feb. 09, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading curator of regulatory-grade…

Human Acellular Vessel™ (HAV™) Biologics License Application Granted Priority Review by U.S. FDA for the Treatment of Vascular Trauma

2 years ago

– BLA submission supported by results from Phase 2/3 clinical trial and outcomes of real-world use of the HAV under…

Performance Health Systems and HPN Holdings Execute Letter of Intent to Merge

2 years ago

Northbrook, Illinois--(Newsfile Corp. - February 9, 2024) - Performance Health Systems LLC, the manufacturer and distributor of Power Plate ®…